2022 is starting on a worrisome note; patience warranted
13/01/22 -"While the fundamental metrics (i.e. DCF and NAV) continue to point to healthy upside potential (taking into consideration the long-term virtues of Philips’ offerings), the near-term is fraught with ..."
Pages
63
Language
English
Published on
13/01/22
You may also be interested by these reports :
13/03/26
In addition to a downward revision to our estimates, we have also incorporated a 30% discount to peer-based valuation metrics to account for business ...
12/03/26
We have revised our 2025 figures downward as actuals came in weaker than expected, starting with a 3.5% miss on the top line. We were overly ...
05/03/26
Elekta’s Q3 profitability exceeded consensus expectations. Organic sales growth was recorded in EMEA and APAC, while the Americas exhibited weakness. ...
05/03/26
Amplifon reported another quarterly performance miss, with both sales and profitability falling short of the company-compiled consensus. Although the ...